smv3 news | smv3.ch

Preclinical drug development

Outsourced early development – Managing a preclinical development with partner PKI

We congratulate MALDI bioapplications specialist mabritec AG to its upcoming 10th anniversary and its new website

University of Oxford spinoff “OMass Technologies” visits Switzerland on march 16, 2018 – interested in meeting them?

Read about our work for Art exhibition “TonArt-TonWerk-DieZweite” in Lausen

smv3.ch enters Swiss Trade Register as GmbH

The University of Basel hires smv3.ch for an analytical lecture in the ‘Master of Drug Sciences’ course